MedPath
HSA Approval

WILISAN RINGWORM COMPOUND LOTION

SIN06396P

WILISAN RINGWORM COMPOUND LOTION

WILISAN RINGWORM COMPOUND LOTION

July 4, 1991

CHONG PARK MEDICAL HALL (SINGAPORE) PTE. LTD.

CHONG PARK MEDICAL HALL (SINGAPORE) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantCHONG PARK MEDICAL HALL (SINGAPORE) PTE. LTD.
Licence HolderCHONG PARK MEDICAL HALL (SINGAPORE) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

LOTION

TOPICAL

Medical Information

D02AE20

xd 02 ae 20

Manufacturer Information

CHONG PARK MEDICAL HALL (SINGAPORE) PTE. LTD.

CHONG PARK MEDICAL HALL SDN BHD

Active Ingredients

RESORCINOL

2% w/v

Resorcinol

SALICYLIC ACID

5% w/v

Salicylic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

WILISAN RINGWORM COMPOUND LOTION - HSA Approval | MedPath